← Leaderboards
Saira Ahmad
Eldec Pharmaceuticals, Inc.
$2,331,547
Attributed
$2,331,547
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2022–23$2M$1.5M$1M$500K$0
'22
'23
Funding mix
By agency
NIH$2,331,547 · 2
By mechanism
R44$2,072,426 · 1
R43$259,121 · 1
Top collaborators
No co-investigators on record.
Most similar at Eldec Pharmaceuticals, Inc.
Same institution · by research overlap
- Richard Joseph Shea$1,340,686
Others in their field
Other Rising Stars on “Palate”
- David T. Kent · Vanderbilt University Medical Center$3,120,041
- Timothy R. Brick · Pennsylvania State University, The$2,120,222
- Sora Shin · Virginia Polytechnic Inst And St Univ$1,686,252
- Ziyaur Rahman · Texas A&M University Health Science Ctr$1,458,071
- Asher Y. Rosinger · Pennsylvania State University, The$1,387,992
- Sang Jin Lee · Wake Forest University Health Sciences$1,310,942
Research focus
PalateCell MembraneLeukocyte ElastaseNovel StrategiesStaphylococcus AureusCellsImmuneInflammatory ResponseNasal EpitheliumNeutrophiliaPeptidomimeticsPseudomonas AeruginosaPeptidesNeutrophilGlosso-SterandrylBacterial InfectionsImmune ResponseInflammationLungBacteriaDrug KineticsEquilibriumChronic InfectionBirth
Grant awards (4)
Novel Strategies to Clear Bacteria from the CF Lung$977,764
R44 · FY2023 · HL · contact PI
Novel Peptide Immunomodulators for Treating Sepsis$259,121
R43 · FY2023 · AI · contact PI
Novel Strategies to Clear Bacteria from the CF Lung$94,743
R44 · FY2023 · HL · contact PI
Novel Strategies to Clear Bacteria from the CF Lung$999,919
R44 · FY2022 · HL · contact PI